Paras Healthcare Limited IPO Details
MainboardListed
EQGMP TodayLive
₹13(+1.9%)
Est. Listing: ₹706
7-Day Trend
7 days ago: ₹9Latest: ₹13
Price Band₹660 - ₹693Lot: 21 Shares
Min Outlay₹13,860Retail Category
Closes On23 Oct 2026Bidding Deadline
Total Demand2.34xSubscription Book
Paras Healthcare Limited IPO DetailsCore Specs
IPO Bidding Dates | 21 Oct 2026 to 23 Oct 2026 |
Allotment Date | 26 Oct 2026 |
Listing Date | 28 Oct 2026 |
Issue Price Band | ₹660 - ₹693 |
Market Lot Size | 21 Shares |
Face Value | ₹1 per share |
Total Issue Size | 2,09,23,520 Shares (₹1450.00 Cr) |
Fresh Issue | 72,15,007 Shares (₹500.00 Cr) |
Offer For Sale (OFS) | 1,37,08,513 Shares (₹950.00 Cr) |
Listing Exchange(s) | NSE, BSE |
Pre-Issue Shares | 10,09,86,187 |
Post-Issue Shares | 10,82,01,194 |
Lot(s) Distribution
| Application | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 21 | ₹14,553 |
| sHNI (Min) | 14 | 294 | ₹2,03,742 |
| bHNI (Min) | 69 | 1,449 | ₹10,04,157 |
Company Financials (In Crores)
| Period Ended | Jun-26 | Mar-26 | Mar-25 | Mar-24 |
|---|---|---|---|---|
| Assets | 2202.88 | 2071.14 | 1810.45 | 1477.66 |
| Revenue | 478.75 | 1628.78 | 1314.21 | 1151.02 |
| Net Worth | 444.96 | 394.94 | 280.49 | 338.51 |
| Borrowing | 888.89 | 854.1 | 727.93 | 547.53 |
| PAT | 49.68 | 43.83 | -57.98 | -15.33 |
| Reserves | 434.86 | 384.84 | 270.73 | 328.75 |
Key Performance Indicators (KPI)
| Metric | Jun-26 | Mar-26 | Mar-25 | Mar-24 |
|---|---|---|---|---|
| ROCE (%) | - | - | - | - |
| RONW (%) | 11.83 | 12.98 | -18.73 | -8.32 |
| EPS (₹) | 4.92 | 4.34 | -5.94 | -1.57 |
| P/E Ratio | - | - | - | - |
About Paras Healthcare Limited
Paras Healthcare Limited, incorporated in December 1987 as Arbian Frozen Foods Private Limited, is a clinical specialty-focused hospital platform providing tertiary and quaternary healthcare services across North India, Bihar and Jharkhand under the “Paras Health” brand. As of March 31, 2026, the company operated eight hospitals with a combined capacity of 2,211 beds across Gurugram, Panchkula, Patna, Darbhanga, Kanpur, Udaipur, Ranchi and Srinagar. Its key clinical specialties include cardiac sciences, oncology, neurosciences, gastro sciences, orthopedics and sports injury, and renal sciences, collectively contributing 74.70% of revenue in Fiscal 2026. With more than 20 years of operating experience, Paras Healthcare follows a balanced expansion strategy covering mature, emerging and new hospitals. The company plans to add a 300-bed hospital in Gurugram and a 500-bed hospital in Ludhiana, taking its total bed capacity to 3,011 by March 2028. As of March 31, 2026, the company had 4,670 employees, including 1,011 doctors and 1,665 nurses.
Strengths & Growth Drivers
- Large Healthcare Network & First-Mover Advantage: The company is one of the largest healthcare providers in North India, Bihar and Jharkhand by bed capacity, with 2,211 beds across eight hospitals as of June 30, 2026. Several hospitals were among the first corporate hospitals in their respective markets.
- Strong Focus on Specialized Treatment: Cardiac, oncology, neuro, gastro, orthopedics and renal care contributed 74.70%, 71.92% and 72.34% of operating revenue in FY2026, FY2025 and FY2024, respectively. The company also has dedicated ICU facilities and transplant programs.
- Flexible & Cost-Efficient Business Model: The company operates hospitals through owned, leased, revenue-sharing and public-private partnership models, supporting cost-efficient expansion. Its capital expenditure per bed was ₹7.70 million as of June 30, 2026.
Risk Factors
- History of Losses: The company reported consolidated losses of ₹10.24 million, ₹579.83 million and ₹153.31 million in the three months ended June 30, 2025, FY2025 and FY2024, respectively. There is no guarantee that the profitability achieved in FY2026 will continue.
- Losses in Subsidiaries: Its subsidiaries, PHRPL and PMHPL, reported combined losses of ₹203.82 million, ₹520.89 million, ₹822.38 million and ₹872.69 million in the three months ended June 30, 2025, FY2026, FY2025 and FY2024, respectively, as their hospitals continue to expand operations.
- High Employee Attrition: The company experienced high attrition among doctors, nurses and other staff, with rates of 12.01%, 16.09%, 60.38%, 66.74% and 65.27% during the relevant periods. Failure to retain staff could affect service quality and business operations.
Company Promoters
- Dharminder Kumar Naga
Lead Manager(s)
Bofa Securities India Limited, Jm Financial Limited, Nuvama Wealth Management Limited
Current GMP Today+₹13Live Unofficial Premium
Estimated Listing Price₹14566.00Cap Price (₹14553) + GMP (₹13)
Estimated Listing Gain+0.1%Expected ROI per Share
Paras Healthcare Limited Daily GMP Trend HistoryLive Daily Trend
| GMP Date | IPO Price | GMP (₹) | Est. Listing Price | Expected Gain (%) | Last Updated |
|---|---|---|---|---|---|
| 28 Oct 2026 | ₹693 | +₹13 | ₹706.00 | +1.9% | 04:13 AM |
| 27 Oct 2026 | ₹693 | +₹16 | ₹709.00 | +2.3% | 11:03 AM |
| 25 Oct 2026 | ₹693 | +₹12 | ₹705.00 | +1.7% | 10:16 AM |
| 23 Oct 2026 | ₹693 | +₹12 | ₹705.00 | +1.7% | 06:37 PM |
| 23 Oct 2026 | ₹693 | +₹11 | ₹704.00 | +1.6% | 10:58 AM |
| 22 Oct 2026 | ₹693 | +₹13 | ₹706.00 | +1.9% | 06:32 PM |
| 21 Oct 2026 | ₹693 | +₹25 | ₹718.00 | +3.6% | 06:34 PM |
| 20 Oct 2026 | ₹693 | +₹50 | ₹743.00 | +7.2% | 06:32 PM |
| 19 Oct 2026 | ₹693 | +₹78 | ₹771.00 | +11.3% | 07:00 AM |
| 18 Oct 2026 | ₹693 | +₹92 | ₹785.00 | +13.3% | 11:58 AM |
| 17 Oct 2026 | ₹693 | +₹96 | ₹789.00 | +13.9% | 04:29 AM |
| 16 Oct 2026 | ₹693 | +₹97 | ₹790.00 | +14.0% | 04:27 AM |
| 15 Oct 2026 | ₹693 | +₹115 | ₹808.00 | +16.6% | 04:52 AM |
| 14 Oct 2026 | ₹693 | +₹51 | ₹51.00 | +7.4% | 04:10 PM |
| 14 Oct 2026 | ₹693 | ₹0 | ₹0.00 | 0.0% | 12:35 PM |
| 14 Oct 2026 | ₹693 | +₹75 | ₹75.00 | +10.8% | 04:30 PM |
| 05 Oct 2026 | ₹693 | ₹0 | ₹0.00 | 0.0% | 08:16 AM |
Subscription Details (No. of Shares)Live Demand Book
| Category | Shares Offered | Shares Applied | Subscription Demand |
|---|---|---|---|
| QIB | 62,77,056 | 2,03,81,592 | 0x |
| NIB | 31,38,528 | 21,66,507 | 0x |
| HNIs(10L +) | 20,92,352 | 12,89,883 | 0x |
| HNIs (2-10L) | 10,46,176 | 8,76,624 | 0x |
| RETAIL | 20,92,352 | 43,95,678 | 0x |
Day Wise Subscription Details
| Day | Date | QIB (x) | NII (x) | Retail (x) | Total (x) |
|---|---|---|---|---|---|
| Day 1 | - | 0x | 0x | 0x | 0x |
| Day 2 | - | 0x | 0x | 0x | 0x |
| Day 3 | - | 0x | 0x | 0x | 0x |
IPO Reservation Breakup
| Investor Category | Shares Offered | Allocation (%) |
|---|---|---|
| Anchor | 94,15,584 | 45% |
| QIB | 62,77,056 | 30% |
| HNI | 31,38,528 | 15% |
| RETAIL | 20,92,352 | 10% |
Official IPO Documents & Filings
Red Herring Prospectus (RHP)
Complete issue guidelines, risks, financials, and company profile.
Draft Red Herring (DRHP)
Initial draft submitted to SEBI before price discovery.
Paras Healthcare Limited IPO Review & FAQ
Everything you need to know about IPO GMP, Kostak, and listing expectations.
As of today, Paras Healthcare Limited IPO Grey Market Premium (GMP) is trading at ₹13 per share. With an issue cap price of ₹693, the expected listing price is ₹706 (+1.9% gain).
UPCOMING21 OCT
OPEN21 OCT
CLOSE23 OCT
LISTED28 OCT
Quick NavigationAuto-Synced
Issue Key Information
Allotment StatusPrice Band₹660 - ₹693
Issue Cap Price₹693
Market Lot Size21 Shares
Min Retail Outlay₹13,860
Total Issue Size₹1450.00 Cr
Listing ExchangesNSE, BSE
RegistrarLink Intime India Private Limited
IPO Lot & Return Calculator
1 Lot(s)
Total Shares Applied:21 shares
Required Investment (At Cap):₹14,553
Expected Listing Gain (@ GMP):+₹273
Estimated Portfolio Value:₹14,826